Urinary angiotensin-converting enzyme 2 increases in diabetic nephropathy by angiotensin II type 1 receptor blocker olmesartan
Conclusion:
Olmesartan may have the unique effect of increasing urinary ACE2 levels. However, whether this contributes to olmesartan’s renoprotective effect must be examined further.
Source: Journal of the Renin-Angiotensin-Aldosterone System : JRAAS - Category: Biomedical Science Authors: Abe, M., Oikawa, O., Okada, K., Soma, M. Tags: Original Articles Source Type: research
More News: Biomedical Science | Carisoprodol | Chronic Kidney Disease | Diabetes | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Liver | Soma | Study | Urology & Nephrology